ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Supreme Court Declines Appeal on Access to Experimental Therapies.

January 18, 2008

Acting Commissioner Tells Grassley He Supports “Academic Freedom” at The Agency, but “At A Proper Time.”

December 1, 2006

CHOP Training Conference Planned

January 23, 1981

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002

Centers’ Problems Get Increasing Attention From Staff, Advisors

August 20, 1976

SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer

October 28, 2005